Role of the CARD15 Gene in the Pathogenesis of Crohn Disease: Phenotypic Classification and Prognostic Implications

Scandinavian Journal of Gastroenterology

Volumn 38, Issue 11, 2003, Pages 1107-1114

  Murillo, L S ^a   Morre S A ^a   Pena A S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BACTERIAL PROTEIN; CASPASE 9; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GENE PRODUCT; HLA B27 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERNALIN; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ASIAN; BURKHOLDERIA; CARD15 GENE; CAUCASIAN; CHROMOSOME 16; CROHN DISEASE; DROSOPHILA; ENVIRONMENTAL FACTOR; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE PHENOTYPE CORRELATION; GRANULOMATOSIS; HUMAN; IMMUNE RESPONSE; INTESTINE FLORA; JEW; LEUCINE RICH REPEAT; LISTERIA MONOCYTOGENES; MISSENSE MUTATION; NEGRO; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; SALMONELLA TYPHIMURIUM; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION; SPONDYLOARTHROPATHY; TRANSGENIC ANIMAL; ULCERATIVE COLITIS; YERSINIA PESTIS;

ANIMALS; CROHN DISEASE; FRAMESHIFT MUTATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 0344686430     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310005703     Document Type: Review

References (79)

1. Marteau P. Inflammatory bowel disease. Endoscopy 2002;34: 63-8.
2. Shanahan F. Crohn's disease. Lancet 2002;359:62-9.
3. Cho JH. The Nod2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease. Inflamm Bowel Dis 2001;7:271-5.
4. Elson CO. Genes, microbes, and T cells: new therapeutic targets in Crohn's disease. N Engl J Med 2002;346:614-6.
5. Sartor RB, Rath HC, Lichtman SN, van Tol EA. Animal models of intestinal and joint inflammation. Baillieres Clin Rheumatol 1996;10:55-76.
6. Lichtman SN, Keku J, Schwab JH, Sartor RB. Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect Immun 1991;59:555-62.
7. Sartor RB. Review article: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther 1997;11 Suppl 3:17-22; discussion 3.
8. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92:5S-11S.
9. Harper PH, Truelove SC, Lee EC, et al. Split ileostomy and ileocolostomy for Crohn's disease of the colon and ulcerative colitis: a 20 year survey. Gut 1983;24:106-13.
10. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4.
11. Van Heel DA, McGovern DP, Jewell DP. Crohn's disease: genetic susceptibility, bacteria, and innate immunity. Lancet 2001;357:1902-4.
12. Grandbastien B, Peeters M, Franchimont D, et al. Anticipation in familial Crohn's disease. Gut 1998;42:170-4.
13. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996;111:597-603.
14. Meucci G, Vecchi M, Torgano G, et al. Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group). Gastroenterology 1992;103:514-9.
15. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379:821-3.
16. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
17. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
18. Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276:4812-8.
19. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-8.
20. Slow E. Identification of a Crohn's disease susceptibility gene. Clin Genet 2001;60:174-6.
21. McGovern DP, van Heel DA, Ahmad T, Jewell DP. NOD2 (CARD15), the first susceptibility gene for Crohn's disease. Gut 2001;49:752-4.
22. Inohara N, Ogura Y, Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol 2002;5:76-80.
23. Beutler B. Autoimmunity and apoptosis: the Crohn's connection. Immunity 2001;15:5-14.
24. Inohara N, Nunez G. The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene 2001; 20:6473-81.
25. Kobayashi K, Inohara N, Hernandez LD, et al. RICK/Rip2/ CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002;416:194-9.
26. Kobe B, Deisenhofer J. The leucine-rich repeat: a versatile binding motif. Trends Biochem Sci 1994;19:415-21.
27. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001;11:725-32.
28. Jang LK, Lee ZH, Kim HH, et al. A novel leucine-rich repeat protein (LRR-1): potential involvement in 4-1BB-mediated signal transduction. Mol Cells 2001;12:304-12.
29. Marino M, Braun L, Cossart P, Ghosh P. Structure of the InIB leucine-rich repeats, a domain that triggers host cell invasion by the bacterial pathogen L. monocytogenes. Mol Cell 1999;4:1063-72.
30. Hartman AB, Venkatesan M, Oaks EV, Buysse JM. Sequence and molecular characterization of a multicopy invasion plasmid antigen gene, ipaH, of Shigella flexneri. J Bacteriol 1990;172: 1905-15.
31. Miao EA, Scherer CA, Tsolis RM, et al. Salmonella typhimurium leucine-rich repeat proteins are targeted to the SPI1 and SPI2 type in secretion systems. Mol Microbiol 1999;34:850-64.
32. Van Gijsegem F, Gough C, Zischek C, et al. The hrp gene locus of Pseudomonas solanacearum, which controls the production of a type III secretion system, encodes eight proteins related to components of the bacterial flagellar biogenesis complex. Mol Microbiol 1995;15:1095-114.
33. Marino M, Braun L, Cossart P, Ghosh P. A framework for interpreting the leucine-rich repeats of the Listeria internalins. Proc Natl Acad Sci USA 2000;97:8784-8.
34. Hugot JP. [Role of NOD2 gene in Crohn's disease.] Gastroenterol Clin Biol 2002;26:13-5.
35. Judge T, Lichtenstein GR. The NOD2 gene and Crohn's disease: another triumph for molecular genetics. Gastroenterology 2002; 122:826-8.
36. Frankish H. Crohn's gene identified. Lancet 2001;357:1678.
37. Hugot JP, Lesage S, Zouali H, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease (#247). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-29.
38. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-57.
39. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
40. Bonen DK, Ogura Y, Nicolae DL, et al. Functional and genetic characterization of major CD-associated NOD2 variants. M1411. Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-296.
41. Crane AM, Bradbury L, Van Heel DA, et al. Role of NOD2 variants in spondylarthritis. Arthritis Rheum 2002;46:1629-33.
42. Van der Paardt M, Crusius JBA, De Koning MHMT, et al. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes and Immunity 2003;4:77-8.
43. Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002;136:896-907.
44. Miceli-Richard C, Zouali H, Lesage S, et al. CARD15/NOD2 analyses in spondylarthropathy. Arthritis Rheum 2002;46: 1405-6.
45. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001;29:19-20.
46. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
47. Sugimura M, Kinouchi Y, Takahashi S, et al. Sequence analysis of the NOD2 gene in Japanese patients with Crohn's disease. M1402. Gastroenterology, Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A294.
48. Negoro K, Kinouchi Y, Hiwatashi N, et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 1999;117: 1062-8.
49. Nakajima A, Matsuhashi N, Kodama T, et al. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 1995;109:1462-7.
50. Yamazaki K, Takazoe M, Tanaka T, et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002;47:469-72.
51. Bonen DK, Nicolae DL, Moran T, et al. Racial differences in Nod2 variation: characterization of Nod2 in African-Americans with Crohn's disease (#248). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-29.
52. Adams KE, Quak EJ, Bryce M, et al. The impact of the NOD2 frameshift risk allele in Australian CD (#M1415). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-297.
53. Yang H, Taylor KD, Lin Y, et al. Evidence for additional mutations in the NOD2 gene conferring risk for Crohn's disease (CD) in Ashkenazi Jews (M1404). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-295.
54. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
55. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24 Suppl 170:2-6.
56. Murillo L, Crusius JB, van Bodegraven AA, et al. CARD15 gene and the classification of Crohn's disease. Immunogenetics 2002; 54:59-61.
57. Burenhult G. De Eerste Mensen. Geïllustreerde geschiedemis van mensenheid. Dutch edn, 1994. Sheena Coupe Utrecht, The Netherlands.
58. Walvoort HC, Peña AS. Crohn's disease: a challenge to the entity concept 1988. Elsevier, B.V. Florida, USA.
59. Fiol M. Panel II Morbus Crohn. In: Proceedings of the International Congress of Gastroenterology (ASNEMG). 1961. Excerpta Medica Foundation, Amsterdam, Leiden/Noordwijk, The Netherlands 20-24 April 1960. p. 450.
60. Pena AS. [Crohn's disease in Spain. Don Carlos Marina Fiol, 30 years ago]. Rev Esp Enferm Dig 1991;80:219-20.
61. Gasche C, Alizadeh BZ, Pena AS. Genotype-Phenotype correlations: How many disorders constitute IBD? Review in depth. Eur J Gastroenterol Hepatol 2002. In press.
62. Vermeire S, Wild G, Kocher K, et al. CARD15 Genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002; 71:74-83.
63. Vermeire S, Louis E, Rutgeerts P, et al. NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology 2002;123:106-11.
64. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122:854-66.
65. Radlmayr M, Torok HP, Martin K, Folwaczny C. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002;122:2091-2.
66. Vermeire S, Cousineau J, Dufresne L, et al. NOD2/CARD15 mutations in Crohn's disease in Quebec: prevalence and association with clinical phenotypes(M1407). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-295.
67. Zhou Z, Lin XY, Akolkar P, et al. Variation at NOD2 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population (#M1409). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-296.
68. Vavassori P, Biancone L, De Nigris F, et al. NOD2 gene mutation and clinical pattern of Crohn's disease (M1412). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-296.
69. Folwaczny C, Radlmayr M, Martin K, Toeroek P. The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease (#M1414). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002; 122:A-297.
70. Van der Linde K, Boor PC, Houwing-Duistermaat JJ, et al. NOD2 and Crohn's disease: healthy homozygous carriers of 3020insc mutation (M1417). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-297.
71. Abreu MT, Taylor KD, Lin YC, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002;123:679-88.
72. Crichton DN, Arnott IDR, Watts D, et al. NOD2/CARD15 mutations in a Scottish Crohn's disease population (#M1420). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-298.
73. Vermeire S, Esters N, Pierik M, et al. Detailed study on phenotypical associations of NOD2/CARD15 mutations in Crohn's disease (M1413). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-296.
74. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002;359:1661-5.
75. Hampe J, Grebe J, Nikolaus S, et al. The NOD2 genotype and the clinical course of Crohn's disease (#249). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-29.
76. Louis E, Hugot JP, Colombel JF, et al. NOD2/CARD15 mutations in Crohn's disease are associated with young age at diagnosis and ileal location. 2002. Gastroenterol, San Francisco, CA, M1405.
77. Annese V, Latiano A, Andreoli A, et al. Mutations of NOD2 gene weakly correlate with the Vienna classification of Crohn's disease (CD) (#M1408). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-295.
78. Vermeire S, Reinisch W, Joossens S, et al. NOD2/CARD15 genotyping in patients with indeterminate colitis (IC): helpful towards definitive diagnosis? (M1416). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-297.
79. Vavassori P, Borgianni P, D'Apice MR, et al. Frequence of 3020insc mutation of the NOD2 gene in Crohn's disease: an Italian study (M1418). Gastroenterology. Digestive Disease Week and The 103rd Annual Meeting of the American Gastroenterological Association 2002;122:A-297,8.